Clinical Trial Update: In Vivo Glycocalyx as Predictor of Complications After Cardiac Surgery

View source ↗

Summary

A clinical trial investigating whether in vivo glycocalyx can predict complications after cardiac surgery has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Endothelial Dysfunction

Snippet

Sponsor: University Hospital, Rouen | Conditions: Endothelial Dysfunction, Cardiovascular Diseases | Status: TERMINATED